Immune-mediated liver injury induced by PD-1/PD-L1 checkpoint inhibitors is different from idiosyncratic drug-induced liver injury

被引：0
|
作者：
Wang, Yan [1 ]
Meng, Yao [1 ]
Zhang, Mengmeng [1 ]
Guo, Tiantian [1 ]
Chen, Wei [1 ]
Liu, Liwei [2 ]
Zhao, Xinyan [1 ]
机构：
[1] Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Natl Clin Res Ctr Digest Dis,Key Lab Translat Med, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Youan Hosp, Dept Liver Dis 4, Difficult & Complicated Liver Dis & Artificial Li, Beijing, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-326
引用
收藏
页码：S121 / S121
页数：1
相关论文
共 50 条
  • [21] PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
    Liu, Jinhua
    Chen, Zichao
    Li, Yaqun
    Zhao, Wenjie
    Wu, JiBiao
    Zhang, Zhen
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [22] Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies
    Wang, Dongxu
    Lin, Jianzhen
    Yang, Xu
    Long, Junyu
    Bai, Yi
    Yang, Xiaobo
    Mao, Yilei
    Sang, Xinting
    Seery, Samuel
    Zhao, Haitao
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
  • [23] Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies
    Dongxu Wang
    Jianzhen Lin
    Xu Yang
    Junyu Long
    Yi Bai
    Xiaobo Yang
    Yilei Mao
    Xinting Sang
    Samuel Seery
    Haitao Zhao
    Journal of Hematology & Oncology, 12
  • [24] PD-1/PD-L1 immune-checkpoint inhibitors in glioblastoma: A concise review
    Caccese, Mario
    Indraccolo, Stefano
    Zagonel, Vittorina
    Lombardi, Giuseppe
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 135 : 128 - 134
  • [25] Covalent small-molecule inhibitors of the PD-1/PD-L1 immune checkpoint
    Maslanka, A.
    Kitel, R.
    Konopka, J.
    Skalniak, L.
    FEBS OPEN BIO, 2024, 14 : 329 - 330
  • [26] Exploring immune checkpoint inhibitors: Focus on PD-1/PD-L1 axis and beyond
    Aden, Durre
    Zaheer, Samreen
    Sureka, Niti
    Trisal, Monal
    Chaurasia, Jai Kumar
    Zaheer, Sufian
    PATHOLOGY RESEARCH AND PRACTICE, 2025, 269
  • [27] The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma
    Mahoney, Kathleen M.
    Freeman, Gordon J.
    McDermott, David F.
    CLINICAL THERAPEUTICS, 2015, 37 (04) : 764 - 782
  • [28] Immune checkpoint inhibitors targeting PD-1/PD-L1 in the treatment of human lymphomas
    Ribatti, Domenico
    Cazzato, Gerardo
    Tamma, Roberto
    Annese, Tiziana
    Ingravallo, Giuseppe
    Specchia, Giorgina
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [29] Neurological adverse events associated with PD-1/PD-L1 immune checkpoint inhibitors
    Zhou, Yanting
    Li, Hongyan
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [30] Anti PD-1/PD-L1 Immune checkpoint inhibitors - addition - EML and EMLc
    SELECTION AND USE OF ESSENTIAL MEDICINES: REPORT OF THE WHO EXPERT COMMITTEE ON SELECTION AND USE OF ESSENTIAL MEDICINES, 2019 (INCLUDING THE 21ST WHO MODEL LIST OF ESSENTIAL MEDICINES AND THE 7TH WHO MODEL LIST OF ESSENTIAL MEDICINES FOR CHILDREN), 2019, 1021 : 314 - 331
12345